Crossmark

Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma

Published Online: 2022-01-07

Published Print: 2022-04

Authors

Matsuyama, Ryusei

Mori, Ryutaro

Ota, Yohei

Homma, Yuki

Yabusita, Yasuhiro

Hiratani, Seigo

Murakami, Takashi

Sawada, Yu

Miyake, Kentaro

Shimizu, Yasuhiro

Kumamoto, Takafumi

Endo, Itaru
License Information

Text and Data Mining valid from 2022-01-07

Version of Record valid from 2022-01-07
More Information

Article History

Received: 22 July 2021

Accepted: 30 November 2021

First Online: 7 January 2022

Disclosure

: The authors declare that they have no conflict of interest.

Document is current